Kjell Öberg
谢尔·厄伯格
MD, PhD
Professor Emeritus of Endocrine Oncology内分泌肿瘤学荣誉教授
👥Biography 个人简介
Prof. Kjell Öberg is a founding pioneer of modern NET medicine at Uppsala University. Over five decades, he established chromogranin A as the key NET biomarker, defined carcinoid crisis management, and shaped global NET classification, diagnosis, and treatment protocols.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Chromogranin A as NET Biomarker
Established chromogranin A as the principal serum biomarker for NET diagnosis, monitoring, and prognosis—a discovery that remains foundational to clinical NET management worldwide.
NET Classification and Diagnosis
Contributed to WHO classification systems for NETs and led efforts to standardize diagnostic workup including imaging and pathological grading across international centers.
Representative Works 代表性著作
The diagnosis and management of the neuroendocrine tumors
Endocrine-Related Cancer (1997)
Seminal review article defining clinical management principles for NETs, cited thousands of times and used as a primary educational reference globally.
Chromogranin A in the diagnosis and prognosis of neuroendocrine tumors
Journal of Endocrinology (2009)
Comprehensive analysis of chromogranin A utility as a diagnostic and prognostic biomarker, solidifying its role in clinical practice.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
James Yao
MD Anderson Cancer Center
Matthew Kulke
Boston Medical Center / Boston University
Emily Bergsland
University of California, San Francisco (UCSF)
Eric Liu
Rocky Mountain Cancer Centers
关注 谢尔·厄伯格 的研究动态
Follow Kjell Öberg's research updates
留下邮箱，当我们发布与 Kjell Öberg（Uppsala University）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment